Succinyl-CoA:3-ketoacid CoA transferase deficiency presenting as recurrent refractory ketoacidosis in an infant

Noopur Kulkarni; Madhumati Otiv; Chaitanya Datar

doi:10.18203/2349-3291.ijcp20263330

Authors

Noopur Kulkarni Department of Pediatrics, KEM Hospital and Research Centre, Pune, Maharashtra, India https://orcid.org/0009-0002-2312-413X
Madhumati Otiv Department of Pediatrics, KEM Hospital and Research Centre, Pune, Maharashtra, India
Chaitanya Datar Department of Pediatrics, KEM Hospital and Research Centre, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20263330

Keywords:

Succinyl-CoA:3-ketoacid CoA transferase deficiency, SCOT deficiency, OXCT1, Ketoacidosis, Ketolysis disorder

Abstract

Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is a rare disorder of ketone body utilization caused by impairment of the OXCT1 gene, leading to recurrent life-threatening ketoacidosis despite preserved glycemia. We report an 8-month-old female infant with recurrent episodes of severe high anion gap metabolic acidosis with marked ketosis and preserved blood glucose requiring peritoneal dialysis and mechanical ventilation. Metabolic investigations demonstrated isolated ketone body accumulation and whole exome sequencing identified a homozygous variant of uncertain significance (VUS) in OXCT1, ultimately confirming SCOT deficiency in the appropriate biochemical and clinical context. This case highlights the importance of considering ketolysis defects in infants with recurrent ketoacidosis and preserved glycemia, and demonstrates the utility of extracorporeal therapy in refractory metabolic crises.

References

Grünert SC, Foster W, Schumann A, Lund A, Pontes C, Roloff S, et al. Succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) deficiency: A rare and potentially fatal metabolic disease. Biochimie. 2021;183:55-62.

Kolb H, Kempf K, Röhling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 2021;19(1):313.

Fukao T, Shintaku H, Kusubae R, Zhang GX, Nakamura K, Kondo M, et al. Patients homozygous for the T435N mutation of succinyl-CoA:3-ketoacid CoA Transferase (SCOT) do not show permanent ketosis. Pediatr Res. 2004;56(6):858-63.

Bahe A. Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency presenting as ketosis with hyperglycemia: A case report. J Pediatr Crit Care. 2022;9:19-22.

Amirkashani D, Asadollahi M, Hosseini R, Talebi S, Golchehre Z, Keramatipour M. A Novel Mutation in the OXCT1 Gene Causing Succinyl-CoA:3-Ketoacid CoA Transferase (SCOT) Deficiency Starting with Neurologic Manifestations. Iran J Child Neurol. 2023;17(2):127-33.

Sass JO, Fukao T, Mitchell GA. Inborn Errors of Ketone Body Metabolism and Transport: An Update for the Clinic and for Clinical Laboratories. J Inborn Errors Metab Screen. 2018;6:232640981877110.

Yıldız Y, Azapağası E. Rare cause of high anion gap metabolic acidosis in an infant: Succinyl‐CoA:3‐ketoacid transferase deficiency. J Paediatr Child Health. 2019;55(11):1395-6.

Zheng D, Hooper M, Spencer-Manzon M, Pierce R. A Case of Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency Presenting with Severe Acidosis in a 14-Month-Old Female: Evidence for Pathogenicity of a Point Mutation in the OXCT1 Gene. J Pediatr Intensive Care. 2018;07(01):062-6.

Chandran P, Kc S, Mp J, Am S. SCOT Deficiency-A Fatal Metabolic Disorder Treated with Peritoneal Dialysis. Indian J Pediatr. 2023;90(5):528.